Острая сердечная недостаточность и микроРНК
https://doi.org/10.26442/2075082X.2019.2.000030
Аннотация
Об авторах
С. Н. НасоноваРоссия
Д. Р. Миндзаев
Россия
И. В. Жиров
Россия
С. Н. Терещенко
Россия
Список литературы
1. Weber J.A, Baxter D.H, Zhang S et al. The microRNA spectrum in 12 body fluids. Clin Chem 2010; 56: 1733-41.
2. Romakina V.V, Zhirov I.V, Nasonova S.N et al. Micro RNA as Biomarkers of Cardiovascular Diseases: Large Opportunities of Small Molecules. Cardiology 2018; 58 (1): 66-71. DOI: 10.18087/cardio.2018.1.10083
3. Givertz M.M, Teerlink J.R, Albert N.M et al. Acute decompensated heart failure: update on new and emerging evidence and directions for future research. J Card Fail 2013; 19: 371-89.
4. Maisel A.S, Richards A.M, Pascual-Figal D, Mueller C. Serial ST2 testing in hospitalized patients with acute heart failure. Am J Cardiol 2015; 115: 32B-37B.
5. Pascual-Figal D.A, Caballero L, Sanchez-Mas J, Lax A. Prognostic markers for acute heart failure. Expert Opin Med Diagn 2013; 7: 379-92.
6. Ouwerkerk W, Voors A.A, Zwinderman A.H. Factors influencing the predictive power of models for predicting mortality and/or heart-failure hospitalization in patients with heart failure. JACC Heart Fail 2014; 2: 429-36.
7. Rahimi K, Bennett D, Conrad N et al. Risk prediction in patients with heart failure. JACC Heart Fail 2014; 2: 440-6.
8. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37: 2129-200.
9. Bayés-Genis A, Lanfear D.E, de Ronde M.W.J et al. Pinto: Prognostic value of circulating microRNAs on heart failure-related morbidity and mortality in two large diverse cohorts of general heart failure patient. Eur J Heart Fail 2018; 20: 67-75.
10. Kochetov A.G, Lyang O.V, Gimadiev R.R et al. Expression of circulating microRNA in chronic heart failure in patients with cardiovascular pathologies. Lab Serv 2016; 1: 26-32. DOI: 10.17116/labs20165126-32
11. Masson S, Batkai S, Beermann J et al. Circulating microRNA-132 levels improve risk prediction for heart failure hospitalization in patients with chronic heart failure. Eur J Heart Failure 2018; 20: 78-85.
12. Tijsen A.J, Creemers E.E, Moerland P.D et al. MiR423-5p as a circulating biomarker for heart failure. Circ Res 2010; 106: 1035-9.
13. Ellis K.L, Cameron V.A, Troughton R.W et al. Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients. Eur J Heart Fail 2013; 15: 1138-47.
14. Seronde M.F, Vausort M, Gayat E.J et al. GREAT Network. Circulating microRNAs and outcome in patients with acute heart failure. PLoS One 2015; 10: e0142237.
15. Bruno N, ter Maaten J.M, Ovchinnikova E.S et al. MicroRNAs relate to early worsening of renal function in patients with acute heart failure. Int J Cardiol 2016; 203: 564-9.
16. Ovchinnikova E.S, Schmitter D, Vegter E.L et al. Signature of circulating microRNAs in patients with acute heart failure. Eur J Heart Fail 2016; 18: 414-23.
17. Vegter E.L, Schmitter D, Hagemeijer Y et al. Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure. Int J Cardiol 2016; 224: 231-9.
18. Vegter E.L, van der Meer P, Voors A.A. Associations between volume status and circulating microRNAs in acute heart failure. Eur J Heart Fail 2017; 19 (8): 1077-8.
19. Melman Y.F, Shah R, Danielson K et al. Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot Study. Circulation 2015; 131: 2202-16.
20. Xiao J, Gao R, Bei Y et al. Circulating miR-30d predicts survival in patients with acute heart failure. Cell Physiol Biochem 2017; 41: 865-74.
21. Van Boven N, Kardys I, van Vark L.C et al. Serially measured circulating microRNAs and adverse clinical outcomes in patients with acute heart failure. Eur J Heart Fail 2018; 20: 89-96.
22. Жиров И.В., Кочетов А.Г., Засеева А.В. и др. МикроРНК в диагностике хронической сердечной недостаточности: состояние проблемы и результаты пилотного исследования. Системные гипертензии. 2016; 13 (1): 39-46.
23. Goren Y, Kushnir M, Zafrir B et al. Serum levels of microRNAs in patients with heart failure. Eur J Heart Fail 2012; 14: 147-54
Рецензия
Для цитирования:
Насонова С.Н., Миндзаев Д.Р., Жиров И.В., Терещенко С.Н. Острая сердечная недостаточность и микроРНК. Системные гипертензии. 2019;16(2):42-46. https://doi.org/10.26442/2075082X.2019.2.000030
For citation:
Nasonova S.N., Mindzaev D.R., Zhirov I.V., Tereshchenko S.N. Acute heart failure and microRNA. Systemic Hypertension. 2019;16(2):42-46. https://doi.org/10.26442/2075082X.2019.2.000030